Dr. Daniel P Barboriak

Claim this profile
Studies Glioblastoma
Studies Brain Cancer
1 reported clinical trial
5 drugs studied

Clinical Trials Daniel P Barboriak is currently running

Image of trial facility.

Advanced Imaging Techniques

for Glioblastoma

This phase II trial studies whether different imaging techniques can provide additional and more accurate information than the usual approach for assessing the activity of tumors in patients with newly diagnosed glioblastoma. The usual approach for this currently is magnetic resonance imaging (MRI). This study is trying to learn more about the meaning of changes in MRI scans after treatment, as while the appearance of some of these changes may reflect progressing tumor, some may be due the treatment. Dynamic susceptibility contrast (DSC)-MRIs, along with positron emission tomography (PET) and/or magnetic resonance (MR) spectroscopy, may help doctors tell which changes are a reflection of the treatment and which changes may be due to progressing tumor.
Recruiting1 award Phase 26 criteria

More about Daniel P Barboriak

Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Daniel P Barboriak has experience with
  • Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging
  • Fluciclovine F18
  • Gadolinium-Chelate
  • Magnetic Resonance Spectroscopy
  • Positron Emission Tomography
Breakdown of trials Daniel P Barboriak has run
Glioblastoma
Brain Cancer

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Daniel P Barboriak specialize in?
Daniel P Barboriak focuses on Glioblastoma and Brain Cancer. In particular, much of their work with Glioblastoma has involved IDH negative patients, or patients who are undergoing treatment.
Is Daniel P Barboriak currently recruiting for clinical trials?
Yes, Daniel P Barboriak is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Daniel P Barboriak has studied deeply?
Yes, Daniel P Barboriak has studied treatments such as Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging, Fluciclovine F18, Gadolinium-Chelate.
What is the best way to schedule an appointment with Daniel P Barboriak?
Apply for one of the trials that Daniel P Barboriak is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top